Combinatorial discovery of tumor targeting peptides using phage display

Journal of Cellular Biochemistry

Volumn 90, Issue 3, 2003, Pages 509-517

  Landon, Linda A ^a   Deutscher, Susan L ^a,b  

^a University of Missouri   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bacteriophage display; Peptide; Tumor targeting

Indexed keywords

ALANYLCYSTEINYLASPARTYLCYSTEINYLARGINYLGLYCYLASPARTYLCYSTEINYLPHENYLALANYLC YSTEINYLGLYCINE; ALANYLGLUTAMYLPROLYLMETHIONYLPROLYLHISTIDYLSERYLLEUCYLASPARAGINYLPHENYLALAN YLSERYLGLUTAMINYLTYROSYLLEUCYLTRYPTOPHYLTYROSYLTHREONINE; ARGINYLVALYLVALYLLYSYLGLUTAMYLSERYLARGININE; ASPARTYLPROLYLARGINYLTHREONYLPROLYLGLYCYLSERINE; CYSTEINYLARGINYLARGINYLHISTIDYLTRYPTOPHYLGLYCYLPHENYLALANYLGLUTAMYLPHENYLAL ANYLCYSTEINE; CYSTEINYLASPARAGINYLGLYCYLARGINYLCYSTEINE; CYSTEINYLGLYCYLPHENYLALANYLGLUTAMYLCYSTEINYLVALYLARGINYLGLUTAMINYLCYSTEINYL PROLYLGLUTAMYLARGINYLCYSTEINE; CYSTEINYLLEUCYLSERYLSERYLARGINYLLEUCYLASPARTYLALANYLCYSTEINE; CYSTEINYLPROLYLGLYCYLPROLYLGLUTAMYLGLYCYLALANYLGLYCYLCYSTEINE; CYSTEINYLTHREONYLTHREONYLHISTIDYLTRYTOPHYLGLYCYLPHENYLALANYLTHREONYLLEUCYLC YSTEINE; CYSTEINYLVALYLALANYLLEUCYLCYSTEINYLARGINYLGLUTAMYLALANYLCYSTEINYLGLYCYLGLUT AMYLGLYCYLCYSTEINE; HISTIDYLGLYCYLARGINYLPHENYLALANYLISOLEUCYLLEUCYLPROLYLTRYPTOPHYLTRYPTOPHYLT YROSYLALANYLPHENYLALANYLSERYLPROLYLSERINE; HISTIDYLLEUCYLGLUTAMINYLISOLEUCYLGLUTAMINYLPROLYLTRYPTOPHYLTYROSYLPROLYLGLU TAMINYLISOLEUCYLSERINE; HISTIDYLTHREONYLMETHIONYLTYROSYLTYROSYLHISTIDYLHISTIDYLTYROSYLGLUTAMINYLHIS TIDYLHISTIDYLLEUCINE; LYSYLCYSTEINYLCYSTEINYLTYROSYLSERYLLEUCINE; METAL; METHIONYLALANYLARGINYLALANYLLYSYLGLUTAMIC ACID; METHIONYLALANYLARGINYLSERYLGLYCYLLEUCINE; METHIONYLCYSTEINYLPROLYLLYSYLHISTIDINYLPROLYLLEUCYLGLYCYLCYSTEINE; METHIONYLGLUTAMINYLLEUCYLPROLYLLEUCYLALANYLTYROSINE; METHIONYLMETHIONYLGLYCYLVALYLGLYCYLTHREONYLSERINE; METHIONYLSERYLARGINYLTHREONYLMETHIONYLSERINE; PEPTIDE DERIVATIVE; PEPTIDE LIBRARY; SERYLMETHIONYLSERYLISOLEUCYLALANYLARGINYLLEUCINE; SERYLTRYPTOPHYLLEUCYLALANYLTYROSYLPROLYLGLYCYLALANYLVALYLSERYLTYROSYLARGINY LTYROSYLSERYLALANYLTYROSYLPROLYLASPARTYLSERYLVALYLPROLYLMETHIONYLMETHIONYLSERINE; TYROSYLSERYLALANYLLEUCYLGLUTAMYLGLUTAMYLGLYCINE; TYROSYLTYROSYLALANYLTRYTOPHYLHISTIDYLTRYPTOPHYLTYROSYLALANYLTRYTOPHYLSERYLP ROLYLLYSYLSERYLVALINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALYLPROLYLTRYPTOPHYLMETHIONYLGLUTMYLPROLYLALANYLTYROSYLGLUTAMINYLARGINYLPH ENYLALANYLLEUCINE;

AMINO ACID SEQUENCE; BACTERIOPHAGE; CANCER; CHELATION; COMBINATORIAL CHEMISTRY; DIAGNOSTIC IMAGING; DRUG TARGETING; FLUORESCENCE; GENETIC ENGINEERING; INTERNALIZATION; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STABILITY; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; COMBINATORIAL CHEMISTRY TECHNIQUES; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; MICE; MOLECULAR SEQUENCE DATA; NEOPLASMS; PEPTIDE LIBRARY; PEPTIDES; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0141885261     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10634     Document Type: Review

References (35)

1. Arap W, Pasqualini R, Ruoslahti E. 1998. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279:377-380.
2. Arap W, Haedicke W, Bernasconi M, et al. 2002a. Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci USA 99:1527-1531.
3. Arap W, Kolonin MG, Trepel M, et al. 2002b. Steps toward mapping the human vasculature by phage display. Nat Med 8:121-127.
4. Blasberg R. 2002. PET imaging of gene expression. Eur J Cancer 38:2137-2146.
5. Chen J, Cheng Z, Miao Y, et al. 2002. Alpha-melanocyte-stimulating hormone peptide analogs labeled with technetium-99m and indium-111 for malignant melanoma targeting. Cancer 94:1196-1201.
6. Ellerby HM, Arap W, Ellerby LM, et al. 1999. Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med 5:1032-1038.
7. Essler M, Ruoslahti E. 2002. Molecular specialization of breast vasculature: A breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc Natl Acad Sci USA 99:2252-2257.
8. Glinsky VV, Glinsky GV, Rittenhouse-Olson K, et al. 2001. The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res 61:4851-4857.
9. Goodson RJ, Doyle MV, Kaufman SE, et al. 1994. High-affinity urokinase receptor antagonists identified with bacteriophage peptide display. Proc Natl Acad Sci USA 91:7129-7133.
10. Heppeler A, Froidevaux S, Eberle AN, et al. 2000. Receptor targeting for tumor localisation and therapy with radio-peptides. Curr Med Chem 7:971-994.
11. Hetian L, Ping A, Shumei S, et al. 2002. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor. J Biol Chem 277:43137-43142.
12. Hillairet De Boisferon M, Raguin O, Thiercelin C, et al. 2002. Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model. Bioconjugate Chem 13:654-662.
13. Houghten RA, Pinilla C, Blondelle SE, et al. 1991. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 354:84-86.
14. Houimel M, Schneider P, Terskikh A, et al. 2001. Selection of peptides and synthesis of pentameric peptabody molecules reacting specifically with ErbB-2 receptor. Int J Cancer 92:748-755.
15. Karasseva N, Wang N, Jurisson S, et al. 1999. Labeling genetically engineered antibody fragments with 99mTc and 186/188Re In: Nicolini M, Mazzi U, editors. Technitium, rhenium, and other metals in chemistry and nuclear medicine. Padova: SGEditorial. pp 549-552.
16. Karasseva N, Glinsky VV, Chen NX, et al. 2002. Identification and characterization of peptides that bind human ErbB-2 selected from a bacteriophage display library. J Protein Chem 21:287-296.
17. Koivunen E, Arap W, Valtanen H, et al. 1999. Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol 17:768-774.
18. Koolpe M, Dail M, Pasquale EB. 2002. An ephrin mimetic peptide that selectively targets the EphA2 receptor. J Biol Chem 277:46974-46979.
19. Landon LA, Peletskaya EN, Glinsky VV, et al. 2003. Combinatorial evolution of high affinity peptides that bind to the Thomsen-Friedenreich carcinoma antigen. J Protein Chem 22:193-204.
20. Maruta F, Parker AL, Fisher KD, et al. 2002. Identification of FGF receptor-binding peptides for cancer gene therapy. Cancer Gene Therapy 9:543-552.
21. Noda K, Yamasaki R, Hironaka Y, et al. 2001. Selection of peptides that bind to the core oligosaccharide of R-form LPS from a phage-displayed heptapeptide library. FEMS Microbiol Lett 205:349-354.
22. Pasqualini R, Ruoslahti E. 1996. Organ targeting in vivo using phage display peptide libraries. Nature 380:364-366.
23. Peletskaya EN, Glinsky VV, Glinsky GV, et al. 1997. Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries. J Mol Biol 270:374-384.
24. Qiu Y, Ravi L, Kung HJ. 1998. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells. Nature 393:83-85.
25. Rajotte D, Arap W, Hagedorn M, et al. 1998. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest 102:430-437.
26. Romanov VI, Durand DB, Petrenko VA. 2001. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion. Prostate 47:239-251.
27. Scott JK, Smith GP. 1990. Searching for peptide ligands with an epitope library. Science 249:386-390.
28. Smith GP. 1985. Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science 228:1315-1317.
29. Spear MA, Breakefield XO, Beltzer J, et al. 2001. Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells. Cancer Gene Ther 8:506-511.
30. Springer GF, Desai PR, Banatwala I. 1975. Blood group MN antigens and precursors in normal and malignant human breast glandular tissue. J Natl Cancer Institute 54:335-339.
31. Trepel M, Arap W, Pasqualini R. 2002. In vivo phage display and vascular heterogeneity: Implications for targeted medicine. Curr Opin Chem Biol 6:399-404.
32. Van de Wiele C, Dumont F, Dierckx RA, et al. 2001. Biodistribution and dosimetry of (99m)Tc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies. J Nucl Med 42:1722-1727.
33. Waibel R, Alberto R, Willuda J, et al. 1999. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex [comment]. Nat Biotechnol 17:897-901.
34. Zhang J, Spring H, Schwab M. 2001. Neuroblastoma tumor cell-binding peptides identified through random peptide phage display. Cancer Lett 171:153-164.
35. Zwick MB, Shen J, Scott JK. 1998. Phage-displayed peptide libraries. Curr Opin Biotechnol 9:427-436.